Install
- 7,805articles · 30d
- 4+ hour agolatest article
- Aug 15, 2026earliest in window
- 87%with images
- 255avg words
- Economy, Business & Finance 5,596
- Finance & Business 4,817
- News 2,649
- Business & Industrial 1,312
- Finance 916
- Science & Technology 619
- Health & Wellness 557
- Medical 476
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
FDA Clearance Advances Prescription ADHD Therapeutics
1+ week, 6+ day ago (229+ words) Dublin, Aug. 31, 2026 (GLOBE NEWSWIRE) -- The "ADHD Apps Market Size, Share & Trends Analysis Report by App Type, User Age Group, Platform, End Use, Region, and Segment Forecasts, 2026-2033" has been added to ResearchAndMarkets.com's offering. Global ADHD Apps Market to Reach USD…...
National Recovery Month: New Federal Data Reveal Substance Use Treatment Gap
2+ week, 5+ day ago (454+ words) Federal data reveal a significant substance use treatment gap as Transformed by His Promises connects Scripture, neuroscience and repeated practice to lasting change. That principle is central to Transformed by His Promises: A 12-Week Devotional for Freedom from the Psychological…...
Segal Trials Reinforces Leadership in Acute Schizophrenia Research Following Participation in MapLight Therapeutics’ Phase 2 ZEPHYR Study
3+ week, 2+ day ago (181+ words) MapLight Therapeutics recently announced topline results from the multicenter Phase 2 study. Segal Trials is proud to have contributed to this important clinical development program and congratulates MapLight Therapeutics, the participating investigators, study teams, and, most importantly, the patients whose participation…...
Protagenic Therapeutics Receives FDA Pre-IND Feedback Supporting New IND for PT00114 in Generalized Anxiety Disorder
3+ week, 3+ day ago (613+ words) Yahoo Finance Oops, something went wrong U.S. markets close in 6h 10m Protagenic Therapeutics Receives FDA Pre-IND Feedback Supporting New IND for PT00114 in Generalized Anxiety Disorder FDA raises no objection to the Company's planned Phase 1 program design, dose-escalation approach, or CMC and nonclinical…...